BPC-2001

BioPhoenix Co., Ltd. · Phase 2 active Small molecule

At a glance

Generic name	BPC-2001
Also known as	KRN-7000
Sponsor	BioPhoenix Co., Ltd.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BPC-2001 CI brief — competitive landscape report
BPC-2001 updates RSS · CI watch RSS
BioPhoenix Co., Ltd. portfolio CI